cbdMD Statistics
Share Statistics
cbdMD has 8.91M
shares outstanding. The number of shares has increased by -0.02%
in one year.
| Shares Outstanding | 8.91M |
| Shares Change (YoY) | -0.02% |
| Shares Change (QoQ) | 0.06% |
| Owned by Institutions (%) | 53.56% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 45,348 |
| FTD / Avg. Volume | 36.9% |
Short Selling Information
The latest short interest is 37.83K, so 0.42% of the outstanding
shares have been sold short.
| Short Interest | 37.83K |
| Short % of Shares Out | 0.42% |
| Short % of Float | 0.43% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -0.55 and the forward
PE ratio is -9.09.
cbdMD's PEG ratio is
0.01.
| PE Ratio | -0.55 |
| Forward PE | -9.09 |
| PS Ratio | 0.1 |
| Forward PS | 0.4 |
| PB Ratio | 1.03 |
| P/FCF Ratio | -3.15 |
| PEG Ratio | 0.01 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for cbdMD.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.74,
with a Debt / Equity ratio of 0.65.
| Current Ratio | 0.74 |
| Quick Ratio | 0.47 |
| Debt / Equity | 0.65 |
| Debt / EBITDA | -0.85 |
| Debt / FCF | -1.98 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $463,861.12 |
| Profits Per Employee | $-88,098.24 |
| Employee Count | 42 |
| Asset Turnover | 1.84 |
| Inventory Turnover | 3.17 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 50.6% in the
last 52 weeks. The beta is 2.45, so cbdMD's
price volatility has been higher than the market average.
| Beta | 2.45 |
| 52-Week Price Change | 50.6% |
| 50-Day Moving Average | 1.12 |
| 200-Day Moving Average | 0.63 |
| Relative Strength Index (RSI) | 43.75 |
| Average Volume (20 Days) | 122,898 |
Income Statement
In the last 12 months, cbdMD had revenue of 19.48M
and earned -3.7M
in profits. Earnings per share was -1.79.
| Revenue | 19.48M |
| Gross Profit | 12M |
| Operating Income | -3.19M |
| Net Income | -3.7M |
| EBITDA | -1.49M |
| EBIT | -3.32M |
| Earnings Per Share (EPS) | -1.79 |
Full Income StatementBalance Sheet
The company has 2.45M in cash and 1.27M in
debt, giving a net cash position of 1.18M.
| Cash & Cash Equivalents | 2.45M |
| Total Debt | 1.27M |
| Net Cash | 1.18M |
| Retained Earnings | -182.07M |
| Total Assets | 11.54M |
| Working Capital | -2.81M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -352.79K
and capital expenditures -290.01K, giving a free cash flow of -642.81K.
| Operating Cash Flow | -352.79K |
| Capital Expenditures | -290.01K |
| Free Cash Flow | -642.81K |
| FCF Per Share | -0.15 |
Full Cash Flow StatementMargins
Gross margin is 61.57%, with operating and profit margins of -16.37% and -18.99%.
| Gross Margin | 61.57% |
| Operating Margin | -16.37% |
| Pretax Margin | -18.99% |
| Profit Margin | -18.99% |
| EBITDA Margin | -7.67% |
| EBIT Margin | -16.37% |
| FCF Margin | -3.3% |
